Organization Summary

Japanese Clinical Association of Cannabinoids (JCAC) aims to promote cannabinoid studies and exchange knowledge that will contribute to medicine and welfare of Japan.

Cannabinoid has been researched worldwide for medical purposes. JCAC was established for health care workers in September 2015 to accelerate cannabinoid researches and projects in Japan. As the current Japanese law restricts cannabinoid use, our first step is to analyze and evaluate cannabidiol (CBD) clinical researches and use of CBD functional food.

JCAC plans to gain permission for cannabinoid clinical researches in Japan with a help of researchers and health care workers, who have interests in cannabinoid research. We are currently encouraging doctors, dentists, pharmacists, nurses, and researchers to join JCAC and obtain membership. Our first JCAC-edited book “Cannabinoid no kagaku - Science of Cannabinoid” was published on September 27th at the commemorative meeting.

JCAC is the official partner organization of the International Association for Cannabinoid Medicines (IACM) established in March 2000.

Administrative Office of Japanese Clinical Association of Cannabinoids:

1-5-8 Hatanodai Sinagawa Tokyo JAPAN Department of Pharmacokinetics SHOWA UNV. School of Pharmacy